Impact of smoking on pemphigus

International Journal of Dermatology

Volumn 47, Issue 6, 2008, Pages 567-570

  Valikhani, Mahin ^a   Kavusi, Suzan ^a,b   Chams Davatchi, Cheyda ^a   Hallaji, Zahra ^a   Esmaili, Nafiseh ^a   Ghandi, Narges ^a   Farahani, Farzaneh ^a   Lajevardi, Vahide ^a  

^a UNIVERSITY OF TEHRAN   (Iran)

^b NONE   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; PREDNISOLONE;

ADULT; ARTICLE; CASE CONTROL STUDY; CIGARETTE SMOKING; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE CONTROL; DRUG DOSE REDUCTION; DRUG DOSE REGIMEN; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PEMPHIGUS VULGARIS; RECURRENT DISEASE; RELAPSE; REMISSION; RETROSPECTIVE STUDY; TREATMENT DURATION;

ADULT; AZATHIOPRINE; CASE-CONTROL STUDIES; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; IRAN; MALE; MIDDLE AGED; MUCOUS MEMBRANE; PEMPHIGUS; PREDNISOLONE; RECURRENCE; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SKIN; SMOKING;

EID: 43549095491     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2008.03645.x     Document Type: Article

References (22)

1. Mehta JN, Martin AG. A case of pemphigus vulgaris improved by cigarette smoking. Arch Dermatol 2000; 136: 15-17.
2. Grando SA, Dahl MV. Nicotine and pemphigus. Arch Dermatol 2000; 136: 1269.
3. Brenner S, Tur E, Shapiro J, et al. Pemphigus vulgaris: Environmental factors. Occupational, behavioral, medical, and qualitative food frequency questionnaire. Int J Dermatol 2001; 40: 562-569.
4. Sullivan TP, Elgart GW, Kirsner RS. Pemphigus and smoking. Int J Dermatol 2002; 41: 528-530.
5. Valikhani M, Kavusi S, Chams-Davatchi C, et al. Pemphigus and associated environmental factors: A case-control study. Clin Exp Dermatol 2007; 32: 256-260.
6. Grando SA. Pemphigus in the XXI century: New life to an old story. Autoimmunity 2006; 39: 521-530.
7. Nguyen VT, Arredondo J, Chernyavsky AI, et al. Pemphigus vulgaris acantholysis ameliorated by cholinergic agonists. Arch Dermatol 2004; 140: 327-334.
8. Chams-Davatchi C, Daneshpazhooh M. Prednisolone dosage in pemphigus vulgaris. J Am Acad Dermatol 2005; 53: 547.
9. Misery L. Nicotine effects on skin: Are they positive or negative? Exp Dermatol 2004; 13: 665-670.
10. Baron JA. Beneficial effects of nicotine and cigarette smoking: The real, the possible and the spurious. Br Med Bull 1996; 52: 58-73.
11. Bittoun R. Recurrent aphthous ulcers and nicotine. Med J Aust 1991; 154: 471-472.
12. Birtwistle J, Hall K. Does nicotine have beneficial effects in the treatment of certain diseases? Br J Nurs 1996; 5: 1195-1202.
13. Burkhart CG, Burkhart CN. The use of nicotine in dermatology revisited. Int J Dermatol 2001; 40: 731-732.
14. Chaffins ML, Collison D, Fivenson DP. Treatment of pemphigus and linear IgA dermatosis with nicotinamide and tetracycline: A review of 13 cases. J Am Acad Dermatol 1993; 28: 998-1000.
15. Grando SA. New approaches to the treatment of pemphigus. J Invest Dermatol Symp Proc 2004; 9: 84-91.
16. Iraji F, Yoosefi A. Healing effect of pilocarpine gel 4% on skin lesions of pemphigus vulgaris. Int J Dermatol 2006; 45: 743-746.
17. Chams-Davatchi C, Valikhani M, Daneshpazhooh M, et al. Pemphigus: analysis of 1209 cases. Int J Dermatol 2005; 44: 470-476.
18. Bystryn JC, Rudolph JL. Pemphigus. Lancet 2005; 366: 61-73.
19. Harman KE, Albert S, Black MM. Guidelines for the management of pemphigus vulgaris. Br J Dermatol 2003; 149: 926-937.
20. Samadi Z, Gorouhi F, Davari P, et al. Think globally, act locally: expert opinions from Asia on the diagnosis and treatment of pemphigus vulgaris. Indian J Med Sci 2007; 61: 144-151.
21. Herbst A, Bystryn JC. Patterns of remission in pemphigus vulgaris. J Am Acad Dermatol 2000; 42: 422-427.
22. Grando SA. Cholinergic control of epidermal cohesion. Exp Dermatol 2006; 15: 265-282.